Europe Product OKd for Micro Therapeutics
Dow Jones
Micro Therapeutics Inc., an Irvine medical device company, said Monday that it received European approval to market its Onyx Liquid Embolic System for the treatment of brain aneurysms.
The company said in a news release that it expects commercial orders for the system to begin early next year. The orders will be handled by Guidant Corp., the company’s distribution partner in Europe.
Micro Therapeutics’ stock price lost 6 cents Monday to close at $6.50 a share in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
